Company intelligence / Profile preview

IPS Genomix

Beirut, Beirut Governorate, Lebanon

Ownership: Private
Employees: ~40
Development stage: Other

Overview

IPS Genomix is a commercial provider and distributor of genomic and molecular diagnostic tests in the Middle East and Africa, partnering with US and European laboratories to offer prognostic, predictive and personalized medicine assays; it does not develop its own therapeutics and therefore has no clinical drug pipeline.[1][7][8][12][13]

Therapeutic areas: Oncology
Modalities: DiagnosticsMolecular diagnosticsGenomic testing
Industry: Molecular Diagnostics

Partnerships

MDxHealth (distribution of SelectMDx prostate cancer test in Middle East)[7]Inivata (distribution of InVision liquid biopsy genomic tests in Middle East and Africa)[13]Multiple US and European molecular diagnostic laboratories and companies (various prognostic, predictive and personalized genomic tests)[1][7][8][12][13]

Beyond the preview

Go deeper on IPS Genomix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPS Genomix.

Explore the full profile